Uso de hemoderivados en pacientes adultos con neoplasias hematológicas malignas diagnosticados en el Instituto del cáncer SOLCA Loja durante 2010 al 2014

Abstract

In order to determine the use of blood products, a descriptive, retrospective study was conducted by analyzing the medical records of adult patients with hematologic malignancies diagnosed in Loja SOLCA Cancer Institute during the years 2010-2014. Ninety three medical records were analyzed and found a ratio 1.08:1 men to women with diagnosed of hematologic malignancies during the period described. It was found that the most frequent were leukemias, in a percentage of 49.6%, followed by lymphomas in a percentage of 40.86%. Hematologic malignancy that used larger amount of blood was acute myeloid leukemia, with the platelet concentrates the most widely used at the rate of 588 units, followed by acute lymphocytic leukemia in a number of 433 units of concentrated platelets, during 4 years. Similarly became clear that the number of transfusions with packed red blood cells was 20 times with a total amount of 156 all administered to patients diagnosed with acute lymphocytic leukemia.